Institutional Ownership
Forte Biosciences Inc
CUSIP 34962G208COM NEWFBRXQ1 2026
13D / 13G Filings
29
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
66.0%
Max % of class reported
Institutional Holders
64
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
29 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Janus Henderson Group PLC | 13G/A | 11.4% | 1.43M | SEC |
| 2 | Jan 29, 2026 | Affinity Asset Advisors, LLC | 13G/A | 6.7% | 835.0K | SEC |
| 3 | Jan 20, 2026 | Point72 Asset Management, L.P. | 13G | 6.3% | 793.0K | SEC |
| 4 | Jan 9, 2026 | Oliveira Steven Michael | 13G/A | 2.4% | 300.1K | SEC |
| 5 | Dec 23, 2025 | Affinity Asset Advisors, LLC | 13G | 6.9% | 862.4K | SEC |
| 6 | Nov 14, 2025 | Alger Associates, Inc. | 13G/A | 13.1% | 1.63M | SEC |
| 7 | Nov 14, 2025 | Biotechnology Value Fund L P | 13G/A | 0.5% | 65.3K | SEC |
| 8 | Oct 7, 2025 | Federated Hermes, Inc. | 13G/A | 13.2% | 1.64M | SEC |
| 9 | Sep 5, 2025 | Federated Hermes, Inc. | 13G/A | 11.9% | 1.48M | SEC |
| 10 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 9.9% | 657.5K | SEC |
19 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Forte Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Federated Hermes, Inc. | 1.77M | $45.73M |
| 2 | Fred Alger Management, LLC | 1.27M | $33.00M |
| 3 | Orbimed Advisors LLC | 1.20M | $31.00M |
| 4 | Janus Henderson Group PLC | 1.19M | $30.81M |
| 5 | Affinity Asset Advisors, LLC | 1.01M | $26.21M |
| 6 | Mpm Bioimpact LLC | 1.00M | $25.92M |
| 7 | Adage Capital Partners Gp, L.L.C. | 950.0K | $24.61M |
| 8 | Morgan Stanley | 500.3K | $12.96M |
| 9 | Cable Car Capital, LP | 400.0K | $10.36M |
| 10 | Fmr LLC | 340.7K | $8.82M |